Sclerosing polycystic adenosis of the parotid gland: Diagnosis and management  by Perottino, F. et al.
EC
S
D
F
M
a
b
C
c
G
A
I
S
l
a
c
p
1
duropean Annals of Otorhinolaryngology, Head and Neck diseases (2010) 127, 20—22
LINICAL COMMENTARY
clerosing polycystic adenosis of the parotid gland:
iagnosis and management
. Perottinoa, R. Barnoudb, A. Ambrunc,
. Poupartc, J.-C. Pignatc, O. Merrotc,∗
Escartons Hospital, 24, avenue Adrien-Daurelle, 05100 Brianc¸on, France
Biology and Pathology Center, Croix-Rousse Teaching Hospital, 103, Grande Rue de la Croix-Rousse,
laude-Bernard Lyon-1 University, 69317 Lyon cedex 04, France
ENT and Head and Neck Surgery Department, Croix-Rousse Teaching Hospital, 103,
rande Rue de la Croix-Rousse, 69317 Lyon cedex 04, France
vailable online 24 March 2010
KEYWORDS
Salivary gland;
Polycystic adenosis;
Parotid tumor
Summary
Objective: To describe diagnostic and therapeutic management of a rare parotid lesion: scle-
rosing polycystic adenosis.
Patient and method: We report a case of persistent right intraparotid tumefaction.
Results: A 68-year-old man was referred with a right parotid nodule of 2 years’ evolution.
Cytology diagnosed pleomorphic adenoma, veriﬁed on MRI. Conservative subtotal parotidec-
tomy diagnosed sclerosing polycystic adenosis. Over 1 year’s regular follow-up, there were no
signs of local recurrence.
Conclusion: Sclerosing polycystic adenosis of the parotid gland is a rare and recently described
entity presenting several analogies to the much more frequent cystic mastitis. Although benign
and well-delimited, it requires complete exeresis of the parotid, due to a non-negligible risk of
recurrence.
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clerosing polycystic adenosis (SPA) is a rare salivary gland
esion, ﬁrst described in 1996 by Smith et al. [1]. Its
natomo-clinical features are those of benign and often
omplex mammary lesions such as cystic mastitis. The
rinciple location is the parotid gland, but it has also
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een reported in the submandibular and accessory salivary
lands.
We report a case of SPA of the parotid gland in a 68-year-
ld man. Optimal management was guided by a review of
he literature.linical case
68-year-old man was referred to ENT for right parotid
odule of 2 years’ evolution. He had no medico-surgical his-
.
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mandibular pleomorphic adenoma and parotid oncocytoma
was reported, with serendipitous discovery of a SPA [6].
Cytologic puncture is to be interpreted with caution. In the
present case, it conﬁrmed benignity; in the few cases foundFigure 1 Axial MRI slice (T2 sequence) showing hyposignal of
an intraparotid lesion.
tory. Examination found an isolated 2 cm-diameter mobile,
pain-free juxta-lobular mass, ﬁrm on palpation. The facial
nerve was fully functional and the neck showed no palpa-
ble adenopathy. Ultrasonography found an 18mm-diameter
intraparotid lesion in the posterior part of the inferior pole
of the right parotid. The well-contoured hypo-echogenic US
aspect suggested pleomorphic adenoma or cystadenolym-
phoma and cytology suggested pleomorphic adenoma. MRI
was in favor of a pleomorphic adenoma with an oval nodu-
lar image measuring 19× 14× 13mm with T1 hyposignal
and slight T2 hypersignal, strongly enhanced by gadolin-
ium (Figs. 1 and 2). Conservative subtotal parotidectomy
was performed without any postoperative complications.
Pathology examination found a well-contoured, partially
encapsulated nodular lesion comprising hyperplastic aci-
nous and ductal structures, sometimes harboringmicrocystic
dilatations, within abundant focally inﬂammatory ﬁbrous
and sclerous tissue (Figs. 3 and 4). A few sites of
atypical epithelial hyperplasia were found, free of inva-
sive or in situ carcinoma. Immunohistochemistry using
smooth-muscle anti-actin antibody (DakoCytomation, dilu-
tion 1/4000) found a conserved myoepithelial cell layer,
conﬁrming benignity (Fig. 5). The two subdigastric ganglions
that were harvested showed no invasion. SPA of the parotid
gland was diagnosed. At 1 year’s follow-up, the patient was
free of local recurrence; regular surveillance was main-
tained. There were no functional sequelae.
Discussion
SPA of the parotid gland is a rare benign salivary-gland
lesion, recently described, sharing the anatomopatho-
logic features of very frequent and well-described benign
mammary lesions, often grouped under mastopathy, and
comprising complex lesions including cystic mastitis. In the
international literature, we found 36 cases, with age at
diagnosis ranging from 9 to 84 years for a mean of 40
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pigure 2 Axial MRI slice (T1 sequence) showing hypersignal of
he intraparotid mass, enhanced by gadolinium.
ears, and a sex ratio of 1 [1—10]. Mean tumor size ranged
rom 0.3 to 6 cm. Location was mainly parotid, but also
n the submandibular and accessory salivary glands [1,6,8].
linical features were non-speciﬁc, with progressive devel-
pment of a generally asymptomatic intraparotid mass,
lthough pain was also reported in some cases [1,3]. One
ase was discovered secondarily to surgery for disabling
hronic juvenile parotiditis [2]. Tumors were single, gen-
rally well-delimited and partially encapsulated, and only
uch more rarely multinodular [6]. An association of sub-igure 3 Hematoxylin—Eosin—Saffron× 10. Anatomopatho-
ogic section showing well-contoured, non-encapsulated intra-
arotid tumor.
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Figure 4 Hematoxylin—Eosin—Saffron× 100. Anatomopatho-
logic section showing simple ductal epithelial hyperplasia and
ﬁbrous stroma aspect.
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Rigure 5 Immunohistochemistry showing persistent myoep-
thelial cells marked by smooth-muscle anti-actin antibody.
n the literature, however, hypercellular aspects and more
typical cells suggested diagnosis of low-grade mucoepi-
ermoid carcinoma [4,5]. Microscopic examination of the
ample found sclerous lobules with dense, hyalinized stro-
al collagen supporting sometimes cystized ducts. Stroma
nd epithelial contingents varied according to the tumor,
nd cystic remodeling was also of variable degree. As in
ystic mastitis, duct-type epithelial hyperplasia, with or
ithout more or less severe atypicality, was found in more
han half of cases and was generally interpreted as more or
ess severe dysplasia and in situ carcinoma [3,6,8]. In mam-
ary pathology, it is important to identify dysplastic lesions
iven the risk of subsequent inﬁltrating carcinoma. In sali-
ary gland SPA, carcinomatous degeneration has not been
eported, but cannot be completely ruled out in view of the
mall number of cases and the superﬁcial location of gener-
lly small tumors. Immunohistochemistry, by using speciﬁc
ntibodies (smooth-muscle anti-actin), can conﬁrm myoep-
thelial cell-layer integrity in benign lesions; this layer is lost
[F. Perottino et al.
n carcinomatous lesions. The nature of salivary gland SPA
emains to be established. It may be a reactional inﬂamma-
ory pseudotumoral lesion, but the risk of local recurrence
nd one study reporting it to be monoclonal combine to sug-
est a truly neoplastic origin [8]. Management is surgical,
ith conservative subtotal parotidectomy followed by reg-
lar prolonged surveillance. This attitude is justiﬁed by the
isk of multiple, sometimes late recurrence in case of incom-
lete exeresis, and the risk of carcinomatous degeneration
1,6—8].
onclusion
PA of the parotid gland is a rare benign salivary gland
esion with histologic analogies to sclerosing adenosis of the
ammary gland. Complete surgical exeresis is the reference
reatment, to reduce the risk of recurrence and/or evolu-
ion. Surveillance should be continued over several years.
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